The components of TAF/FTC and TDF/FTC have activity against hepatitis B virus (HBV). When persons with chronic HBV infection are prescribed TDF/FTC or TAF/FTC, these agents will also have an effect on ...
The combination of tenofovir disoproxil fumarate (TDF) and entecavir induces a high rate of viral suppression in patients with chronic hepatitis B virus (HBV) infection who have failed multiple ...
Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination ...